| scholarly article | Q13442814 |
| P2093 | author name string | Hui Sun | |
| Xiaodong Liu | |||
| Xiaoli Liu | |||
| Mengzi He | |||
| Silin Chen | |||
| Dan Cong | |||
| P2860 | cites work | The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells | Q53245125 |
| Upregulation of HGF and c-MET is associated with subclinical central lymph node metastasis in papillary thyroid microcarcinoma. | Q54375509 | ||
| miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation. | Q54431698 | ||
| The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer | Q54540170 | ||
| The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer | Q74215024 | ||
| The combination of TP53INP1, TP53INP2 and AXIN2: potential biomarkers in papillary thyroid carcinoma | Q87525224 | ||
| MicroRNA expression profiles in the management of papillary thyroid cancer | Q38260896 | ||
| A miRNA signature associated with human metastatic medullary thyroid carcinoma. | Q38311922 | ||
| Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers | Q38341871 | ||
| Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance | Q38388971 | ||
| Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma | Q38485412 | ||
| Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma | Q38492280 | ||
| Platelet‐derived growth factor receptor‐α promotes lymphatic metastases in papillary thyroid cancer | Q39323181 | ||
| Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma | Q39448741 | ||
| miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer | Q39484319 | ||
| miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. | Q40720717 | ||
| MicroRNA-138 promotes tau phosphorylation by targeting retinoic acid receptor alpha | Q41438357 | ||
| Radiation exposure does not significantly contribute to the risk of recurrence of Chernobyl thyroid cancer. | Q44775368 | ||
| mRNA expression pattern of retinoic acid and retinoid X nuclear receptor subtypes in human thyroid papillary carcinoma. | Q47720269 | ||
| MicroRNAs establish robustness and adaptability of a critical gene network to regulate progenitor fate decisions during cortical neurogenesis | Q48714627 | ||
| The role of microRNA genes in papillary thyroid carcinoma | Q24535848 | ||
| Progress in molecular-based management of differentiated thyroid cancer | Q26999887 | ||
| Reduced accumulation of specific microRNAs in colorectal neoplasia | Q28211976 | ||
| Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer | Q28262641 | ||
| A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia | Q28279141 | ||
| Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma | Q30718501 | ||
| The miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland. | Q33588077 | ||
| TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer | Q33682388 | ||
| The epidemiology of thyroid disease and implications for screening | Q34064308 | ||
| MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma | Q34147480 | ||
| MicroRNA-195 Inhibits the Proliferation of Human Glioma Cells by Directly Targeting Cyclin D1 and Cyclin E1 | Q34575813 | ||
| Role of miRNA in the regulation of inflammatory genes in staphylococcal enterotoxin B-induced acute inflammatory lung injury and mortality | Q35214593 | ||
| miRNA expression in anaplastic thyroid carcinomas | Q35230925 | ||
| A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping | Q36410621 | ||
| New developments in the diagnosis and treatment of thyroid cancer | Q37238757 | ||
| Deregulation of microRNA expression in thyroid neoplasias | Q38163815 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| papillary thyroid cancer | Q2292945 | ||
| The Cancer Genome Atlas | Q3979425 | ||
| P304 | page(s) | 2271-2277 | |
| P577 | publication date | 2015-08-26 | |
| P1433 | published in | OncoTargets and Therapy | Q7092081 |
| P1476 | title | Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas | |
| P478 | volume | 8 |
| Q47145138 | Clinical significance of miR-34a expression in thyroid diseases - an 18F-FDG PET-CT study |
| Q52653079 | Clinical significance of microRNA-449a in hepatocellular carcinoma with microarray data mining together with initial bioinformatics analysis |
| Q33750895 | Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma |
| Q55472371 | Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma. |
| Q37714468 | Knockdown of Long Non-Coding RNA KCNQ1OT1 Restrained Glioma Cells' Malignancy by Activating miR-370/CCNE2 Axis |
| Q37447873 | MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6. |
| Q38663358 | MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2. |
| Q39179286 | MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer |
| Q64108364 | MicroRNA-221 promotes papillary thyroid carcinoma cell migration and invasion via targeting RECK and regulating epithelial-mesenchymal transition |
| Q37596839 | MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA. |
| Q91796775 | Molecular Signature of Prospero Homeobox 1 (PROX1) in Follicular Thyroid Carcinoma Cells |
| Q33833144 | Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears. |
| Q47096509 | Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes |
| Q39066104 | Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics |
| Q47145035 | Serum miRNAs as Biomarkers for the Diagnosis and Prognosis of Thyroid Cancer: A Comprehensive Review of the Literature |
| Q41709343 | The highly expressed COL4A1 genes contributes to the proliferation and migration of the invasive ductal carcinomas |
| Q97425817 | The role of microRNAs in the pathogenesis of thyroid cancer |
| Q33656421 | VDR mRNA overexpression is associated with worse prognostic factors in papillary thyroid carcinoma |
| Q33850074 | Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment |
| Q47152865 | hsa-miR-29c-3p regulates biological function of colorectal cancer by targeting SPARC. |
| Q92345904 | miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo Signaling in Thyroid Cancer |
| Q53036247 | miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas |
Search more.